Literature DB >> 24753610

Interferon induction of IFITM proteins promotes infection by human coronavirus OC43.

Xuesen Zhao1, Fang Guo, Fei Liu, Andrea Cuconati, Jinhong Chang, Timothy M Block, Ju-Tao Guo.   

Abstract

IFNs are a family of cytokines that are essential for the antiviral response in vertebrates. Not surprisingly, viruses have adapted to encode virulence factors to cope with the IFN response. Intriguingly, we show here that all three types of interferons, IFN-α, IFN-γ, and IFN-λ, efficiently promote infection by a human coronavirus, HCoV-OC43, one of the major etiological agents of common cold, through the induction of IFN-inducible transmembrane (IFITM) proteins. IFITMs typically exert their antiviral function by inhibiting the entry of a broad spectrum of viruses into their host cells, presumably by trapping and degrading invading virions within the endocytic compartments. In contrast, HCoV-OC43 uses IFN-induced human IFITM2 or IFITM3 as an entry factor to facilitate its infection of host cells. Reverse genetics analyses suggest that the structural motifs critical for the IFITM proteins' enhancement of HCoV-OC43 infection are distinct from those required for inhibiting infection by other viruses. We also present evidence showing that IFITM family members work as homo- and hetero-oligomers to modulate virus entry. The observed enhancement of HCoV-OC43 infection by IFNs may underlie the propensity of the virus to invade the lower respiratory tract under inflammatory conditions.

Entities:  

Keywords:  evasion of IFN response; proviral function of IFITM; viral pathogenesis

Mesh:

Substances:

Year:  2014        PMID: 24753610      PMCID: PMC4020042          DOI: 10.1073/pnas.1320856111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.

Authors:  Sinu P John; Christopher R Chin; Jill M Perreira; Eric M Feeley; Aaron M Aker; George Savidis; Sarah E Smith; Andrew E H Elia; Aaron R Everitt; Mehul Vora; Thomas Pertel; Stephen J Elledge; Paul Kellam; Abraham L Brass
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

2.  Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.

Authors:  Jacob S Yount; Bruno Moltedo; Yu-Ying Yang; Guillaume Charron; Thomas M Moran; Carolina B López; Howard C Hang
Journal:  Nat Chem Biol       Date:  2010-07-04       Impact factor: 15.040

3.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

4.  Severity and outcome associated with human coronavirus OC43 infections among children.

Authors:  Andréanne Jean; Caroline Quach; Allison Yung; Makeda Semret
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

5.  Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus.

Authors:  Dong Jiang; Haitao Guo; Chunxiao Xu; Jinhong Chang; Baohua Gu; Lijuan Wang; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

6.  IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.

Authors:  Rajini Mudhasani; Julie P Tran; Cary Retterer; Sheli R Radoshitzky; Krishna P Kota; Louis A Altamura; Jeffrey M Smith; Beverly Z Packard; Jens H Kuhn; Julie Costantino; Aura R Garrison; Connie S Schmaljohn; I-Chueh Huang; Michael Farzan; Sina Bavari
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

7.  IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.

Authors:  Eric M Feeley; Jennifer S Sims; Sinu P John; Christopher R Chin; Thomas Pertel; Li-Mei Chen; Gaurav D Gaiha; Bethany J Ryan; Ruben O Donis; Stephen J Elledge; Abraham L Brass
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

8.  IFITM proteins restrict viral membrane hemifusion.

Authors:  Kun Li; Ruben M Markosyan; Yi-Min Zheng; Ottavia Golfetto; Brittani Bungart; Minghua Li; Shilei Ding; Yuxian He; Chen Liang; James C Lee; Enrico Gratton; Fredric S Cohen; Shan-Lu Liu
Journal:  PLoS Pathog       Date:  2013-01-24       Impact factor: 6.823

9.  IFITM1 is a tight junction protein that inhibits hepatitis C virus entry.

Authors:  Courtney Wilkins; Jessica Woodward; Daryl T-Y Lau; Amy Barnes; Michael Joyce; Nicola McFarlane; Jane A McKeating; D Lorne Tyrrell; Michael Gale
Journal:  Hepatology       Date:  2012-12-12       Impact factor: 17.425

10.  Expression of MS4A and TMEM176 Genes in Human B Lymphocytes.

Authors:  Jonathan Zuccolo; Lili Deng; Tammy L Unruh; Ratna Sanyal; Jeremy A Bau; Jan Storek; Douglas J Demetrick; Joanne M Luider; Iwona A Auer-Grzesiak; Adnan Mansoor; Julie P Deans
Journal:  Front Immunol       Date:  2013-07-15       Impact factor: 7.561

View more
  86 in total

1.  A sorting signal suppresses IFITM1 restriction of viral entry.

Authors:  Kun Li; Rui Jia; Minghua Li; Yi-Min Zheng; Chunhui Miao; Yunfang Yao; Hong-Long Ji; Yunqi Geng; Wentao Qiao; Lorraine M Albritton; Chen Liang; Shan-Lu Liu
Journal:  J Biol Chem       Date:  2014-12-19       Impact factor: 5.157

2.  The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.

Authors:  Yimeng Wang; Qinghua Pan; Shilei Ding; Zhen Wang; Jingyou Yu; Andrés Finzi; Shan-Lu Liu; Chen Liang
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

3.  Not your usual tRNA synthetase: hWARS serves as an enterovirus entry factor.

Authors:  Stanley Perlman; Tom Gallagher
Journal:  J Clin Invest       Date:  2018-10-15       Impact factor: 14.808

4.  Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2.

Authors:  Xuesen Zhao; Fang Guo; Mary Ann Comunale; Anand Mehta; Mohit Sehgal; Pooja Jain; Andrea Cuconati; Hanxin Lin; Timothy M Block; Jinhong Chang; Ju-Tao Guo
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

5.  Low type I interferon response in COVID-19 patients: Interferon response may be a potential treatment for COVID-19.

Authors:  Ahmed Abdulwahid Salman; Mohammed Hussein Waheed; Akeel Abd Ali-Abdulsahib; Zeenah Weheed Atwan
Journal:  Biomed Rep       Date:  2021-03-09

6.  Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.

Authors:  Graham A D Blyth; Wing Fuk Chan; Robert G Webster; Katharine E Magor
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

7.  Functional Mapping of Regions Involved in the Negative Imprinting of Virion Particle Infectivity and in Target Cell Protection by Interferon-Induced Transmembrane Protein 3 against HIV-1.

Authors:  Mathilde Delpeuch; Li Zhong; Romain Appourchaux; Julien Burlaud-Gaillard; Kevin Tartour; George Savidis; Abraham Brass; Lucie Etienne; Philippe Roingeard; Andrea Cimarelli
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

8.  Interferon-inducible LY6E Protein Promotes HIV-1 Infection.

Authors:  Jingyou Yu; Chen Liang; Shan-Lu Liu
Journal:  J Biol Chem       Date:  2017-01-27       Impact factor: 5.157

9.  Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium.

Authors:  Bryce A Schuler; A Christian Habermann; Erin J Plosa; Chase J Taylor; Christopher Jetter; Nicholas M Negretti; Meghan E Kapp; John T Benjamin; Peter Gulleman; David S Nichols; Lior Z Braunstein; Alice Hackett; Michael Koval; Susan H Guttentag; Timothy S Blackwell; Steven A Webber; Nicholas E Banovich; Jonathan A Kropski; Jennifer Ms Sucre
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

10.  w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway.

Authors:  Pinghu Zhang; Zuguo Zheng; Li Ling; Xiaohui Yang; Ni Zhang; Xue Wang; Maozhi Hu; Yu Xia; Yiwen Ma; Haoran Yang; Yunyi Wang; Hongqi Liu
Journal:  Autophagy       Date:  2017-05-17       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.